Skip to main content

Table 5 Base-case analysis per 1978 patients: Costs, Outcomes, and ICER of private sector compared with public sector diabetes care

From: Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran

Outcome

Private sector

Public sector

Difference

Life expectancy

6.99

6.77

0.22

QALE

5.17

4.95

0.22

Treatment costs (US$)

2557.55

1861.76

695.79

Costs of managing complications (US$)

12,827.78

6231.01

6596.77

Total costs (US$)

15,385.33

8092.76

7292.56

ICER (US$)

33,148.02